HongShan

Tracked participation in 1 Atlas company, with 1 explicitly attributed lead.

1portfolio companies

3round participations

1lead positions

$1Bled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Feb 2024Moonshot AISeries B$1Bat $2.5B valuation

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

MAMoonshot AIFrontierMoonshot AI is a Beijing-based frontier AI lab behind the Kimi family of open-weight large language models and the…$20Bvaluation$4.4BraisedRecent roundsGrowth / late-stage round · May 2026$2B · led by Long-Z Investments, Meituan (美团龙珠)C+ round · Feb 2026$700M · led by NineAns Pharmaceutical (九安医疗), WuYuan Capital (五源资本)C round · Dec 2025$500M · led by IDG CapitalMoonshot AI$20BFeb 2024 → May 20263 rounds1 led—

DateCompanyRoundRaisedValuationRoleEvidence

May 07, 2026MAMoonshot AIFrontierMoonshot AI is a Beijing-based frontier AI lab behind the Kimi family of open-weight large language models and the…$20Bvaluation$4.4BraisedRecent roundsGrowth / late-stage round · May 2026$2B · led by Long-Z Investments, Meituan (美团龙珠)C+ round · Feb 2026$700M · led by NineAns Pharmaceutical (九安医疗), WuYuan Capital (五源资本)C round · Dec 2025$500M · led by IDG CapitalMoonshot AIGrowth / late-stage round$2B$20BParticipant

Source ↗+1 ↗

Feb 21, 2024MAMoonshot AIFrontierMoonshot AI is a Beijing-based frontier AI lab behind the Kimi family of open-weight large language models and the…$20Bvaluation$4.4BraisedRecent roundsGrowth / late-stage round · May 2026$2B · led by Long-Z Investments, Meituan (美团龙珠)C+ round · Feb 2026$700M · led by NineAns Pharmaceutical (九安医疗), WuYuan Capital (五源资本)C round · Dec 2025$500M · led by IDG CapitalMoonshot AISeries B$1B$2.5BLead

Source ↗

UndatedMAMoonshot AIFrontierMoonshot AI is a Beijing-based frontier AI lab behind the Kimi family of open-weight large language models and the…$20Bvaluation$4.4BraisedRecent roundsGrowth / late-stage round · May 2026$2B · led by Long-Z Investments, Meituan (美团龙珠)C+ round · Feb 2026$700M · led by NineAns Pharmaceutical (九安医疗), WuYuan Capital (五源资本)C round · Dec 2025$500M · led by IDG CapitalMoonshot AIPre-Series B round (valuation $300M described)$200M$300MParticipant

Source ↗

DateCompanyRoundRaisedValuationRoleEvidence

Source ↗+1 ↗

Source ↗